Literature DB >> 19531689

Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis.

M M Wickremaratchi1, D Perera, C O'Loghlen, D Sastry, E Morgan, A Jones, P Edwards, N P Robertson, C Butler, H R Morris, Y Ben-Shlomo.   

Abstract

BACKGROUND: Previous prevalence studies of Parkinson's disease (PD) in the UK have spanned a 40 year period and have predominantly been in the North of the country. These have presented rates by current age but have not examined this by age at disease onset.
METHODS: A community based prevalence study was undertaken which attempted to identify all clinically diagnosed cases of PD from primary and secondary care for the city of Cardiff, Wales, UK. A meta-analysis of all past studies in the UK, including our own, was also undertaken.
RESULTS: Overall, 380 cases of PD were identified from a population of 292 637 residents, giving a crude prevalence rate of 130 per 100 000 (95% CI 117 to 144) and an age standardised rate of 142 per 100 000 (95% CI 128 156), standardised to the 1997 England and Wales population. Our prevalence rates were very similar to the weighted average of previous UK studies although there was evidence of between study heterogeneity (p = 0.0006). 5.4% and 31.2% of prevalent PD patients had their disease onset below the age of 50 or 65 years, respectively.
CONCLUSIONS: The data suggest that there are no major geographical variations in the prevalence of PD in the UK and that the age adjusted prevalence rate has remained relatively stable over the past 40 years. Although PD risk is far greater in older subjects, patients with young onset are not that uncommon in the community, and health and social care provision should reflect their needs.

Entities:  

Mesh:

Year:  2009        PMID: 19531689     DOI: 10.1136/jnnp.2008.162222

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

Review 1.  Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.

Authors:  Connie Marras; Katja Lohmann; Anthony Lang; Christine Klein
Journal:  Neurology       Date:  2012-03-27       Impact factor: 9.910

2.  The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

Authors:  James Shearer; Colin Green; Carl E Counsell; John P Zajicek
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

3.  Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania.

Authors:  Catherine Dotchin; Ahmed Jusabani; Richard Walker
Journal:  J Neurol       Date:  2011-03-26       Impact factor: 4.849

Review 4.  Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.

Authors:  Katherine A Kitchen Andren; Nicolette M Gabel; Julija Stelmokas; Alyson M Rich; Linas A Bieliauskas
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

5.  The health-related, social, and economic consequences of parkinsonism: a controlled national study.

Authors:  Poul Jennum; Marielle Zoetmulder; Lise Korbo; Jakob Kjellberg
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

Review 6.  [Parkinson's disease. Perioperative management and anesthesia].

Authors:  U Wüllner; J Standop; O Kaut; V Coenen; A Kalenka; F Wappler
Journal:  Anaesthesist       Date:  2012-02       Impact factor: 1.041

7.  Parkinson's disease: how is employment affected?

Authors:  R Murphy; N Tubridy; H Kevelighan; S O'Riordan
Journal:  Ir J Med Sci       Date:  2013-01-17       Impact factor: 1.568

8.  Time trends in incidence of Parkinson's disease diagnosis in UK primary care.

Authors:  Laura Horsfall; Irene Petersen; Kate Walters; Anette Schrag
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

9.  Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States.

Authors:  A W Willis; M Schootman; N Kung; B A Racette
Journal:  Parkinsonism Relat Disord       Date:  2012-10-17       Impact factor: 4.891

10.  How well do we recognise non-motor symptoms in a British Parkinson's disease population?

Authors:  Michele Hu; Jonathan Cooper; Rebecca Beamish; Emma Jones; Richard Butterworth; Lesley Catterall; Yoav Ben-Shlomo
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.